WHO ICTRP trial
Curcumin-piperine supplementation in children with none- alcoholic fatty liver…
IRCT20121216011763N54 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20121216011763N54 |
|---|---|
| Public title | Curcumin-piperine supplementation in children with none- alcoholic fatty liver disease |
| Scientific title | The effect of curcumin-piperine supplementation on inflammatory and oxidative stress factors, sonographic findings and symptom of depression, anxiety and stress in children with nonalcoholic fatty liver disease |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | None- alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified;K76.0 |
| Interventions | Intervention 1: Intervention group: Take one capsule containing curcumin piperine daily (containing 500 mg curcumin extract and 5 mg piperine, Sami labs Ltd., India ) for 10 weeks. Intervention 2: Control group: They will receive one… |
| Registration date | Mar 28, 2022 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: